1 / 22

Symptoms and correlates of emergency medical treatment following the use of MDMA

Symptoms and correlates of emergency medical treatment following the use of MDMA. Lx Addictions , October 24 th – 26 th 2017, Lisbon. Dr. Larissa J. Maier Monica J. Barratt , Jason A. Ferris , & Adam R. Winstock. Overview. Part I The Rationale for the Study

feng
Download Presentation

Symptoms and correlates of emergency medical treatment following the use of MDMA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Symptoms and correlates of emergency medical treatment following the use of MDMA LxAddictions, October 24th – 26th 2017, Lisbon Dr. Larissa J. Maier Monica J. Barratt, Jason A. Ferris, & Adam R. Winstock

  2. Overview Part I The Rationale for the Study Part II The Global Drug Survey (GDS) Part III MDMA &Emergency Medical Treatment

  3. Global drugmarkettrends Results 21,600,000 UNODC (2017) UNODC (2017)

  4. Saferparty (2017) BACKGROUND High purityecstasypills in Europe

  5. Saferparty.ch (2017) BACKGROUND Fixed-site drugcheckingZurich2007 – 2016

  6. Weruntheworld‘slargestdrugsurvey Background GDS2012 15,500 GDS2013 22,000 GDS2014 77,000 GDS2015 95,000 GDS2016 100,000 GDS2017120,000 GDS2018 200,000+

  7. GDS aims to make drug use safer regardless of the legal status of the drugs by sharing information with individuals, communities, health and policy organisations and government.

  8. + Senior Academic Mentor Group + Scientific Advisory Group + International Network Background GDS Core Research Team

  9. Strengths and limitationsofthe GDS EVALUATION Acceptanceamongrecreationaldrugusers (≠ HH surveys) Profile newdrugsquickly (e.g., Mephedrone, DMT, 1P-LSD) Identifyregionaldifferences Real time research Independent Mostly well-educatedyoungadults Not representative

  10. MDMA useforthefirst time Results

  11. EMT MDMA gender & age Results

  12. 2.5% 1.2% Noremarquablecountrydifferences Results

  13. Symptoms relatedto EMT Results Anxiety Confusion Depressedmood Extreme agitation Palpitations Overheating Extreme sweating Paranoia

  14. Wereyouadmittedtohospital? (n=212) Results

  15. MDMA Emergency Medical Treatment Results

  16. Couldthe EMT havebeenavoided? Results Only55.6% (n=134) obtainedthe MDMA from a trustedsource Only29.0% (n=70) hadtriedthe MDMA beforethatnight Only26.6% (n=64) startedthenightwith a testdose Overall, 50.2% (n=121) tookthatnight a bigger dose thantheirusualdose

  17. Drug, set and setting Results 61.4% (n=148) werealreadydrunkwhenstarting MDMA use 5.6 alcoholicdrinksand 1.3l water 27.4%thinkthatthedrugtheyused was adulterated Only57.1%feltfinewithoutphysical (15.6%) or mental (13.7%) healthissuesorboth (13.7%)

  18. MOST EMergencies COULD PROBABLY HAVE BEEN AVOIdED!

  19. @maier_larissa @globaldrugsurvy larissa.maier@hotmail.ch adam@globaldrugsurvey.com

More Related